In this study we specifically focused on whether, and which, chemotherapy agents sensitize tumor cells to immune effector mechanisms; we thus tried to mainly explore the ability of drugs to render tumor cells more susceptible to immunotherapy with IL-18, and did not investigate each drug's overall effects on the immune system. Here, IL18 is linked to neoplasm.